Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
<p>Abstract</p> <p>Background</p> <p>CD4 testing is the recognized gold standard used to stage HIV/AIDS, guide treatment decisions for HIV-infected persons and evaluate effectiveness of therapy. The need for a less expensive surrogate marker that can be used in resource...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2334/12/128 |